TY  - GEN 
AU  - Bonanad, C.
AU  - Raposeiras Roubín, Sergio
AU  - García-Blas, S.
AU  - Núñez-Gil, I.
AU  - Vergara-Uzcategui, C.
AU  - Díez-Villanueva, P.
AU  - Bañeras, J.
AU  - Molins, C.B.
AU  - Aboal, J.
AU  - Carreras, J.
AU  - Bodi, V.
AU  - Gabaldón-Pérez, A.
AU  - Mateus-Porta, G.
AU  - Parada Barcia, Jose Antonio
AU  - Martínez-Sellés, M.
AU  - Chorro, F.J.
AU  - Ariza-Solé, A.
PY  - 2022
SN  - 2077-0383
UR  - http://hdl.handle.net/20.500.11940/20019
AB  - [EN] Clinical practice guidelines recommend extending dual antiplatelet therapy (DAPT) beyond 1 year after acute coronary syndrome (ACS) in patients with high ischemic risk and without high bleeding risk. The aim of this study was to identify...
LA  - en
TI  - Evaluation of the Use of Dual Antiplatelet Therapy beyond the First Year after Acute Coronary Syndrome
DO  - 10.3390/JCM11061680
KW  - AS Vigo
KW  - CHUVI
KW  - IISGS
VL  - 11
ER  -